A copper missile-triggered power coalescence and death vortex within tumor cell mitochondria for synergistic cuproptosis/phototherapy/chemotherapy

• Published in: Nanoscale 2024-08, Vol.16 (34), p.15967-15983
• Main Authors: Jiang, Yicheng, He, Shuhan, Xiang, Niu, Duan, Linghui, Lin, Yuxiang, Huang, Wenyu, Wu, Zhenghong, Qi, Xiaole
• Format: Article
• Language: English
• Subjects: Anticancer properties; Cell death; Chemotherapy; Copper; Copper sulfides; Damage accumulation; Effectiveness; Homeostasis; Light therapy; Mitochondria; Mitochondrial DNA; Radiation damage
• ISSN: 2040-3364; 2040-3372; 2040-3372
• DOI: 10.1039/d4nr02382j

The importance of copper homeostasis in mitochondria and copper-triggered modality of mitochondrial cell death have been confirmed. However, the existing copper-based nanoplatforms are focused on synergistic therapies while the intracellular therapeutic targets are relatively scattered. Effective integration of all targets within mitochondria to generate power coalescence remains a challenge. Herein, we developed a novel copper-based delivery system to trigger power coalescence and death vortex within tumor cell mitochondria. Specifically, a mitochondrial targeting "copper missile" loaded with curcumin (termed as Cur@CuS-TPP-HA, CCTH) was designed for cuproptosis/phototherapy/chemotherapy synergistic anti-tumor therapy. Once the CCTH NPs are shuttled to the mitochondria, near-infrared (NIR) irradiation initiates the release of copper ions and curcumin for in situ drug accumulation in cancer cell mitochondria. An excess of copper ions and curcumin can activate cuproptosis and mitochondrial apoptosis pathways, respectively. When combined, they can cause an increase in reactive oxygen species (ROS), damage to mitochondrial DNA (mt-DNA), and a decrease in energy supply, thereby leading to a "vicious circle" of mitochondrial damage that further enhances the tumor-killing efficacy. As a consequence, this "copper missile" exhibits advanced anti-tumor effects as verified through in vitro assessments and in vivo evaluations using the 4T1 breast tumor model, providing a promising approach for cuproptosis-based synergistic anti-tumor therapy. The CCTH nanoparticles trigger power coalescence and death vortex within tumor cell mitochondria, producing potent anti-tumor efficacy through cuproptosis/phototherapy/chemotherapy synergistic therapy.